#Investigation of #Influenza #H5N1 Virus #Neutralization by Quadrivalent Seasonal #Vaccines, #UK, 2021–2024, https://etidiohnew.blogspot.com/2025/05/investigation-of-influenza-h5n1-virus.html
#Investigation of #Influenza #H5N1 Virus #Neutralization by Quadrivalent Seasonal #Vaccines, #UK, 2021–2024, https://etidiohnew.blogspot.com/2025/05/investigation-of-influenza-h5n1-virus.html
@kopper@brain.d.on-t.work I will Lightning outpost #Neutralization
Structural basis of different #neutralization capabilities of #monoclonal #antibodies against #H7N9 virus, https://etidiohnew.blogspot.com/2024/12/structural-basis-of-different.html
Cross - #neutralization of #Influenza A by #SARS-CoV-2 specific neutralizing #antibodies and polyclonal #plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A? Heliyon, https://www.cell.com/heliyon/fulltext/S2405-8440(24)16669-8?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2405844024166698%3Fshowall%3Dtrue
This #investigation revealed that neutralizing antibodies of #delta #variant cross-reacted with the Influenza A virus, which might protect against influenza viruses and reduce and shift the seasonal influenza circulation during the COVID-19 pandemic.
#Neutralization of #SARS-CoV-2 #KP1, #KP11, #KP2 and #KP3 by #human and murine #sera
Source: npj Vaccines, AbstractWe report SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 neutralizing antibody titers. They displayed increased immune evasion compared to JN.1, especially KP.1 and KP.3, for participants who experienced BF.7/BA.5.2 breakthrough infection or received bivalent (delta/BA.5) vaccine boosting. Second XBB sub-variants breakthrough infection enhanced the neutralization…
#Neutralization and #Stability of #JN1-derived #LB1, #KP23, #KP3 and #KP311 #Subvariants http://biorxiv.org/cgi/content/short/2024.09.04.611219v1?rss=1
We report on the neutralizing #antibody (nAb) #escape, infectivity, #fusion, and stability of these subvariants-LB.1, KP.2.3, KP.3, and KP.3.1.1. Our findings demonstrate that all of these subvariants are highly evasive of nAbs elicited by bivalent #mRNA #vaccine, the #XBB15 monovalent mumps virus-based vaccine, or from infections during the BA.2.86/JN.1 wave.
#SARS-CoV-2 #BA4/5 #infection triggers more cross-reactive FcγRIIIa signaling and #neutralization than #BA1, in the context of #hybrid #immunity, J Virol.: https://journals.asm.org/doi/full/10.1128/jvi.00678-24?af=R
Although this is consistent with enhanced neutralization and FcγRIIIa signaling breadth of BA.4/5 vaccine boosters, the reduced activity against #XBB15 supports the need to update vaccines with XBB sublineage immunogens to provide adequate coverage of these highly antibody evasive variants.
#Evolution and #neutralization #escape of the #SARS-CoV-2 #BA286 subvariant https://www.nature.com/articles/s41467-023-43703-3
The #neuraminidase #activity of #influenza A virus determines the strain-specific sensitivity to #neutralization by respiratory #mucus, J Virol.: https://doi.org/10.1128/jvi.01271-23 #research #biology #library
⚡️ In a series of air operations conducted in northern Iraq and Syria, over 150 terrorists have been neutralized. The Minister of National Defense, Yaşar Güler, emphasized the commitment to intensify the fight against terrorism. The operations targeted terrorist strongholds and destroyed their sources of income and facilities, resulting in significant success. #Counterterrorism #Neutralization #AirOperations https://www.riskmap.com/incidents/1925531/articles/193996461/?utm_source=dlvr.it&utm_medium=mastodon
#Neutralization, effector function and immune #imprinting of #Omicron #variants, Nature: https://www.nature.com/articles/s41586-023-06487-6 #research #immunity #SARS_CoV_2
Tyson GB, Jones S, Logan N, McDonald M, Marshall L, Murcia PR, et al. #SARS-CoV-2 #seroprevalence and cross-variant #antibody #neutralization in #cats, #UK. Emerg Infect Dis. 2023 Jun [date cited]. https://doi.org/10.3201/eid2906.221755
#Beta #variant #COVID19 protein booster #vaccine elicits durable cross- #neutralization against SARS-CoV-2 variants in non-human primates https://www.nature.com/articles/s41467-023-36908-z
#Neutralization of {#SARS-CoV-2 #Omicron} #BQ1, #BQ11, and #XBB {variants} with #RBD-Dimer
#Vaccines, NEJM: https://www.nejm.org/doi/full/10.1056/NEJMc2216233?query=TOC&cid=NEJM%20eToc,%20March%202,%202023%20DM2076332_NEJM_Non_Subscriber&bid=1438415850
#Immunogenicity and #protection of a #variant nanoparticle #vaccine that confers broad #neutralization against #SARS-CoV-2 variants https://www.nature.com/articles/s41467-022-35606-6
#Neutralization activity of #IgG #antibody in #COVID19‑convalescent #plasma against #SARS-CoV-2 variants https://www.nature.com/articles/s41598-023-28591-3